Medstrada

Medstrada is an Israel-based private equity firm that targets early-stage healthcare companies. Its stated investment strategy covers medical devices, digital health platforms, and healthcare services, focusing on startup-stage ventures. The firm's geographical concentration reflects Israel's position as a global leader in health-tech innovation on a per-capita basis.

Public records confirm Medstrada is headquartered in Israel and its investment strategy centers on Israeli healthcare startups. The firm has not publicly disclosed international investment activity. Companies in its target sectors frequently pursue regulatory approvals — such as FDA clearance or CE marking — that open US and European market access, but the firm's direct investment footprint remains Israel-concentrated based on available information.

Medstrada targets early-stage, startup-stage companies according to its stated strategy. This places the firm at the venture-to-growth inflection point, investing in companies commercializing clinical technologies. The firm does not publicly disclose a minimum or maximum check size.

Medstrada has not publicly disclosed its principal team, investment committee structure, or decision-making framework. The firm maintains a limited external profile, and no named investment professionals have been confirmed through public reporting or official communications channels as of mid-2026.

Medstrada is classified as a private equity firm, not a single family office. The firm's capital source — whether it operates as an independent sponsor, manages third-party limited partner commitments, or deploys a proprietary balance sheet — is not publicly disclosed. Its regulatory classification and fund structure remain unconfirmed in the absence of public filings.